Abstract P1-08-01: Combination checkpoint inhibition and epigenetic modulation promotes tumor suppression and improves survival in Her2+ models of breast cancer

MLA

Todd D. Armstrong, et al. “Abstract P1-08-01: Combination Checkpoint Inhibition and Epigenetic Modulation Promotes Tumor Suppression and Improves Survival in Her2+ Models of Breast Cancer.” Cancer Research, vol. 78, Feb. 2018, pp. P1-08. EBSCOhost, https://doi.org/10.1158/1538-7445.sabcs17-p1-08-01.

APA

Todd D. Armstrong, Hayley S Ma, ET Roussos Torres, Elizabeth M. Jaffee, & Brian Christmas. (2018). Abstract P1-08-01: Combination checkpoint inhibition and epigenetic modulation promotes tumor suppression and improves survival in Her2+ models of breast cancer. Cancer Research, 78, P1-08. https://doi.org/10.1158/1538-7445.sabcs17-p1-08-01

Chicago

Todd D. Armstrong, Hayley S Ma, ET Roussos Torres, Elizabeth M. Jaffee, and Brian Christmas. 2018. “Abstract P1-08-01: Combination Checkpoint Inhibition and Epigenetic Modulation Promotes Tumor Suppression and Improves Survival in Her2+ Models of Breast Cancer.” Cancer Research 78 (February): P1-08. doi:10.1158/1538-7445.sabcs17-p1-08-01.